› Forums › General Melanoma Community › Can someone please explain what this article is talking about?
- This topic has 9 replies, 3 voices, and was last updated 10 years, 8 months ago by Linny.
- Post
-
- February 11, 2014 at 2:48 pm
Scancell Gets US Orphan Drug Tag for Metastatic Melanoma
LONDON (Alliance News) – Scancell Holdings PLC said Tuesday its SCIB1 ImmunoBody metastatic melanoma treatment had been granted orphan drug designation by the US Food and Drug Administration.
This designation means that Scancell can qualify for a 50% tax credit for clinical trials of the treatment, a waiver of the prescription-drug user fee for the drug-approval procedure, and seven years of market exclusivity.
The orphan drug designation is designed for rare diseases that affect less than 200,000 people in the US, or treatments that are not expected to recover the costs of development and marketing the drug.
Shares in the biopharmaceutical company were trading up 5.5% at 37.17 pence Tuesday morning.
—–
What in the world is an SCIB1 ImmunoBody metastatic melanome treatment?
- Replies
-
-
- February 11, 2014 at 3:28 pm
SCIB1 Immunobody is a melanoma vaccine.
This company (Scancell) developed and patented a genetically engineered antibody fragment trade named "Immunobody". You can read about it here: http://www.scancell.co.uk/Apps/Content/html/?fid=6
To this antibody fragment, they can attach pieces of various cancer-specific proteins or "epitopes". By using different epitoes, they hope to be able to develop vaccines for melanoma or lung cancer or kidney cancer, etc. Each of these vaccines will contain the Immunobody part plus the cancer-specific part. You can read more about the SCIB1 anti-melanoma vaccine here: http://www.scancell.co.uk/Apps/Content/HTML/?id=10
-
- February 11, 2014 at 4:13 pm
Fascinating!! Darryel & I were at a presentation in November given by a rep from Bexion Pharm. (They are working on a nanovesicle to treat multiple forms of cancer, and it sounds promising).
Anyway, we met a lady who said she been diagnosed Stage IV some years ago but had participated in a clinical trial for a melanoma vaccine, which apparently worked for her. I don't recall now who was behind that vaccine. At any rate, I thought she was crazy!! Maybe not?!
-
- February 11, 2014 at 4:13 pm
Fascinating!! Darryel & I were at a presentation in November given by a rep from Bexion Pharm. (They are working on a nanovesicle to treat multiple forms of cancer, and it sounds promising).
Anyway, we met a lady who said she been diagnosed Stage IV some years ago but had participated in a clinical trial for a melanoma vaccine, which apparently worked for her. I don't recall now who was behind that vaccine. At any rate, I thought she was crazy!! Maybe not?!
-
- February 11, 2014 at 4:13 pm
Fascinating!! Darryel & I were at a presentation in November given by a rep from Bexion Pharm. (They are working on a nanovesicle to treat multiple forms of cancer, and it sounds promising).
Anyway, we met a lady who said she been diagnosed Stage IV some years ago but had participated in a clinical trial for a melanoma vaccine, which apparently worked for her. I don't recall now who was behind that vaccine. At any rate, I thought she was crazy!! Maybe not?!
-
- February 11, 2014 at 3:28 pm
SCIB1 Immunobody is a melanoma vaccine.
This company (Scancell) developed and patented a genetically engineered antibody fragment trade named "Immunobody". You can read about it here: http://www.scancell.co.uk/Apps/Content/html/?fid=6
To this antibody fragment, they can attach pieces of various cancer-specific proteins or "epitopes". By using different epitoes, they hope to be able to develop vaccines for melanoma or lung cancer or kidney cancer, etc. Each of these vaccines will contain the Immunobody part plus the cancer-specific part. You can read more about the SCIB1 anti-melanoma vaccine here: http://www.scancell.co.uk/Apps/Content/HTML/?id=10
-
- February 11, 2014 at 3:28 pm
SCIB1 Immunobody is a melanoma vaccine.
This company (Scancell) developed and patented a genetically engineered antibody fragment trade named "Immunobody". You can read about it here: http://www.scancell.co.uk/Apps/Content/html/?fid=6
To this antibody fragment, they can attach pieces of various cancer-specific proteins or "epitopes". By using different epitoes, they hope to be able to develop vaccines for melanoma or lung cancer or kidney cancer, etc. Each of these vaccines will contain the Immunobody part plus the cancer-specific part. You can read more about the SCIB1 anti-melanoma vaccine here: http://www.scancell.co.uk/Apps/Content/HTML/?id=10
-
- You must be logged in to reply to this topic.